Development Of Biomarkers Suppliers & Manufacturers

We are a digital health startup that strives to put patients in control of their chronic respiratory disease with unprecedented ease and convenience. Our mission is to develop monitoring solutions that are compatible with patients’ everyday lives. ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Artificial intelligence for every step of pharmaceutical research and development. Our mission is to accelerate drug discovery and drug development by continuously inventing and deploying new artificial intelligence technologies. We provide AI ...

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Our portfolio of innovative products enable timely differential diagnosis, prognosis, management, and optimization of ...

Arc Bio is revolutionizing microbial detection with proprietary, turnkey metagenomic Next-Generation Sequencing (mNGS) workflow and software solutions for fast, precise, and cost-effective analyses. Arc Bio is revolutionizing microbial detection by ...

We are on a mission to “View the Invisible, Know the Unknown”, and have goals to suggest optimal treatments to medical practitioners and to find biomarkers that help to develop the treatment. VUNO Inc. was founded by three insightful leaders in ...

Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...

20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...

Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...

Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital ...

Yashraj Biotech Limited manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogens. YBL has been the preferred partner of most of ...

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...

Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...

ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of 'big RNA data', which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to ...

DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...

BioSensics is a global leader in development of wearable sensors and digital platforms for clinical trials, patient monitoring and health assessment. BioSensics was founded in 2007 by three scientists from Harvard University with a vision of ...

SGS M-Scan is a world leading group of chemical analysis laboratories specialized in chemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...